Overall, the evidence indicates that this is an uncommon event, and the benefits of GLP-1 therapy continue to outweigh the potential risks for most eligible patients
For example, semaglutide for weight loss (Wegovy) begins at 0.25 mg weekly, increasing every four weeks until reaching the maintenance dose of 2.4 mg, as outlined in the product's SmPC
Hyperpigmentation Treatment: Addresses dark spots, acne scars, and uneven patches
Arthritis Res Therapy
This apparent inconsistency between the improvements in auxological parameters and body composition seen in CJC/48 h and CJC/72 h groups and the absence of significant elevation in serum IGF-I has been extensively reported by others and our group (2, 3, 8, 17)
However, not all individuals experience every stage (23)